Artrya Ltd

Artrya Ltd company information, Employees & Contact Information

Explore related pages

Related company profiles:

Artrya is an applied artificial intelligence healthcare company that works alongside clinicians to improve the diagnosis of coronary heart disease and develop a holistic overview of a patient at risk. We are working on deep learning algorithms enabling the prediction and prevention of acute coronary events.

Company Details

Employees
50
Founded
-
Address
Perth, Western Australia 6000, Au
Email
co****@****rya.com
Industry
Medical Equipment Manufacturing
NAICS
Medical Equipment and Supplies Manufacturing
Surgical and Medical Instrument Manufacturing
Surgical Appliance and Supplies Manufacturing
Dental Equipment and Supplies Manufacturing
Ophthalmic Goods Manufacturing
Dental Laboratories
Website
artrya.com
HQ
Perth, Western Australia
Looking for a particular Artrya Ltd employee's phone or email?

Artrya Ltd Questions

News

FDA clearance of Salix® Coronary Plaque module - Investing News Network

FDA clearance of Salix® Coronary Plaque module Investing News Network

FDA clears CCTA AI coronary plaque assessment from Artrya - Cardiovascular Business

FDA clears CCTA AI coronary plaque assessment from Artrya Cardiovascular Business

Artrya clears key US milestone for coronary device, targets FDA filing by year-end - BiotechDispatch

Artrya clears key US milestone for coronary device, targets FDA filing by year-end BiotechDispatch

FDA clears Artrya’s AI-based coronary anatomy software - BioWorld MedTech

FDA clears Artrya’s AI-based coronary anatomy software BioWorld MedTech

Small-cap tearaway Artrya doesn’t skip a beat, launches $65m raising - AFR

Small-cap tearaway Artrya doesn’t skip a beat, launches $65m raising AFR

How Investors May Respond To Artrya (ASX:AYA) Raising A$80 Million for US FDA-Approved Salix Expansion - simplywall.st

How Investors May Respond To Artrya (ASX:AYA) Raising A$80 Million for US FDA-Approved Salix Expansion simplywall.st

Will an A$80 Million Raise and FDA Approval Reshape Artrya's (ASX:AYA) US Ambitions? - Yahoo Finance

Will an A$80 Million Raise and FDA Approval Reshape Artrya's (ASX:AYA) US Ambitions? Yahoo Finance

Artrya (ASX:AYA): With FDA 510(k) approval and $75m in fresh capital, its all systems go! - Stocks Down Under

Artrya (ASX:AYA): With FDA 510(k) approval and $75m in fresh capital, its all systems go! Stocks Down Under

Health Check: ‘Historical milestone’ as FDA approves second Artrya heart device - Stockhead

Health Check: ‘Historical milestone’ as FDA approves second Artrya heart device Stockhead

Artrya Limited’s New ASX Securities Quotation Sparks Market Focus - Kalkine Media

Artrya Limited’s New ASX Securities Quotation Sparks Market Focus Kalkine Media

Perth medtech Artrya raises $80m - businessnews.com.au

Perth medtech Artrya raises $80m businessnews.com.au

Artrya raises $15 million - Australian Manufacturing Forum

Artrya raises $15 million Australian Manufacturing Forum

Artrya share purchase plan closes early after strong investor demand - BiotechDispatch

Artrya share purchase plan closes early after strong investor demand BiotechDispatch

Health Check: Coronary plaque buster Artrya launches $80 million raising - Stockhead

Health Check: Coronary plaque buster Artrya launches $80 million raising Stockhead

Artrya Limited Issues Shares on Performance Rights Exercise - TipRanks

Artrya Limited Issues Shares on Performance Rights Exercise TipRanks

Artrya Limited Announces Quotation of New Securities on ASX - TipRanks

Artrya Limited Announces Quotation of New Securities on ASX TipRanks

Artrya (ASX:AYA): Valuation Insights After $80 Million Equity Raise and Growth Ambitions - Yahoo Finance

Artrya (ASX:AYA): Valuation Insights After $80 Million Equity Raise and Growth Ambitions Yahoo Finance

Artrya Limited Issues Shares Following Performance Rights Exercise - TipRanks

Artrya Limited Issues Shares Following Performance Rights Exercise TipRanks

Artrya Limited Releases 2025 Corporate Governance Statement - TipRanks

Artrya Limited Releases 2025 Corporate Governance Statement TipRanks

Artrya signs US$600,000 contract with Tanner Health, marks first US revenues - Proactive financial news

Artrya signs US$600,000 contract with Tanner Health, marks first US revenues Proactive financial news

Artrya Limited Announces New Securities Quotation on ASX - TipRanks

Artrya Limited Announces New Securities Quotation on ASX TipRanks

FDA clears Artrya’s Salix AI coronary plaque module - BioWorld MedTech

FDA clears Artrya’s Salix AI coronary plaque module BioWorld MedTech

Artrya Limited Launches Share Purchase Plan to Support Expansion - TipRanks

Artrya Limited Launches Share Purchase Plan to Support Expansion TipRanks

Artrya Limited Completes First Tranche of Share Placement, Launches Share Purchase Plan - TipRanks

Artrya Limited Completes First Tranche of Share Placement, Launches Share Purchase Plan TipRanks

Artrya Limited Successfully Completes Oversubscribed Share Purchase Plan - TipRanks

Artrya Limited Successfully Completes Oversubscribed Share Purchase Plan TipRanks

Artrya Limited Issues Shares to Bolster Market Position - TipRanks

Artrya Limited Issues Shares to Bolster Market Position TipRanks

Artrya’s AI tool detects heart disease in real time - InnovationAus.com

Artrya’s AI tool detects heart disease in real time InnovationAus.com

Artrya secures multi-year commercial contract with Sonic Healthcare - BiotechDispatch

Artrya secures multi-year commercial contract with Sonic Healthcare BiotechDispatch

We're Hopeful That Artrya (ASX:AYA) Will Use Its Cash Wisely - simplywall.st

We're Hopeful That Artrya (ASX:AYA) Will Use Its Cash Wisely simplywall.st

Artrya signs US partnership to validate AI for heart disease diagnosis - Mobi Health News

Artrya signs US partnership to validate AI for heart disease diagnosis Mobi Health News

Medtech company Artrya to roll out AI heart disease detecting tool in Australia by next year - Mobi Health News

Medtech company Artrya to roll out AI heart disease detecting tool in Australia by next year Mobi Health News

FDA submission looms as Artrya's AI platform aims to capture the huge cardio diseases market - Stockhead

FDA submission looms as Artrya's AI platform aims to capture the huge cardio diseases market Stockhead

Artrya gets to the heart of AI with ASX listing, $40 million IPO - Proactive financial news

Artrya gets to the heart of AI with ASX listing, $40 million IPO Proactive financial news

Listing gets Artrya moving - businessnews.com.au

Listing gets Artrya moving businessnews.com.au

Artrya co-founder steps down - businessnews.com.au

Artrya co-founder steps down businessnews.com.au

‘Best interests’: Artrya boss John Barrington steps down - The West Australian

‘Best interests’: Artrya boss John Barrington steps down The West Australian

Top Artrya Ltd Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant